A functional soluble form of CTLA-4 is present in the serum of celiac patients and correlates with mucosal injury

International Immunology

Volumn 21, Issue 9, 2009, Pages 1037-1045

  Simone, Rita ^a,d   Brizzolara, Renata ^b   Chiappori, Alessandra ^b   Milintenda Floriani, Francesca ^a   Natale, Clelia ^c   Greco, Luigi ^c   Schiavo, Mara ^b   Bagnasco, Marcello ^b   Pesce, Giampaola ^b   Saverino, Daniele ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY OF VERONA   (Italy)

Author keywords

Autoimmunity; Celiac disease; CTLA 4

Indexed keywords

AUTOANTIBODY; B7 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUTEN; IMMUNOGLOBULIN A; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ADOLESCENT; ADULT; AGED; ANTIGEN BINDING; ANTIGEN FUNCTION; ARTICLE; BLOOD SAMPLING; CELIAC DISEASE; CELL ASSAY; CELL FUNCTION; CHILD; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DIETARY INTAKE; ENZYME LINKED IMMUNOSORBENT ASSAY; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOREGULATION; IN VITRO STUDY; INFANT; INTESTINE INJURY; INTESTINE VILLUS ATROPHY; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMALL INTESTINE MUCOSA; T LYMPHOCYTE; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; ATROPHY; AUTOANTIBODIES; CELIAC DISEASE; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; DOWN-REGULATION; GENOTYPE; GLUTENS; HLA-DQ ANTIGENS; HUMANS; IMMUNOGLOBULIN A; INFANT; INTESTINAL MUCOSA; MIDDLE AGED; T-LYMPHOCYTES; TRANSGLUTAMINASES;

EID: 69749103910     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxp069     Document Type: Article

References (52)

1. Maki, M. and Collin, P. 1997. Celiac disease. Lancet 349:1755.
2. Fasano, A., Berti, I., Gerarduzzi, T. et al. 2003. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: A large multicenter study. Arch. Intern. Med. 163:286.
3. Tommasin, A., Not, T., Kiren, V. et al. 2004. Mass screening for coeliac disease using antihuman transglutaminase antibody assay. Arch. Dis. Child. 89:512.
4. Bingley, P. J., Williams, A. J., Norcross, A. J. et al. 2004. Avon longitudinal study of parents and children study team, undiagnosed celiac disease at age seven: Population based prospective birth cohort study. Br. Med. J. 328:322.
5. Maki, M., Mustalahti, K., Kokkonen, J. et al. 2003. Prevalence of celiac disease among children in Finland. N. Engl. J. Med. 348:2517.
6. Menardo, G., Brizzolara, R., Bonassi, S. et al. 2006. Population screening of celiac disease in a low prevalence area in Italy. Scand. J. Gastroenterol. 41:1414.
7. Van de Wal, Y., Kooy, Y., van Veelen, P. et al. 1998. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J. Immunol. 161:1585.
8. Sollid, L. M. and Thorby, E. 1993. HLA susceptibility genes in celiac disease: Genetic mapping and role in pathogenesis. Gastroenterology 105:910.
9. Sollid, L. M., Markussen, G., Ek, J. et al. 1989. Evidence for a primary association of coeliac disease to a particular HLA-DQ alpha/beta heterodimer. J. Exp. Med. 169:345.
10. Spurkland, A., Sollid, L. M. and Polanco, I. 1992. HLA-DR and -DQ genotype of coeliac disease patients serologically typed to be nonDR3 or nonDR5/7. Hum. Immunol. 35:188.
11. Djilali-Saiah, I., Caillat-Zucman, S., Schmitz, J. et al. 1994. Polymorphism of antigen processing (TAP, LMP) and HLA class II genes in coeliac disease. Hum. Immunol. 40:8.
12. Gianfrani, C., Auricchio, S. and Troncone, R. 2005. Adaptive and innate immune responses in celiac disease. Immunol. Lett. 99:141.
13. Harper, K., Balzano, C., Rouvier, E. et al. 1991. CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J. Immunol. 147:1037.
14. Walunas, T. L., Lenschow, D. J., Bakker, C. Y. et al. 1994. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1:405.
15. Sharpe, A. H. and Freeman, G. J. 2002. The B7-CD28 superfamily. Nat. Rev. Immunol. 2:116.
16. Djilali-Saiah, I., Schmitz, J., Harfouch-Hammoud, E. et al. 1998. CTLA-4 gene polymorphism is associated with predisposition to coeliac disease. Gut 43:187.
17. Tivol, E. A., Borriello, F., Schweitzer, A. N. et al. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541.
18. Waterhouse, P., Penninger, J. M., Timms, E. et al. 1995. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270:985.
19. Yanagawa, T., Hidaka, Y., Guimaraes, V. et al. 1995. CTLA-4 gene polymorphism associated with Graves' disease in Caucasian population. J. Clin. Endocrinol. Metab. 80:41.
20. Nistico, L., Buzzetti, R., Pritchard, L. E. et al. 1996. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Hum. Mol. Genet. 5:1075.
21. Donner, H., Rau, H., Walfich, P. G. et al. 1997. CTLA-4 alanine confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J. Clin. Endocrinol. Metab. 82:143.
22. van Belzen, M. J., Mulder, C. J., Zhernakova, A. et al. 2004. CTLA4 + 49 A/G and CT60 polymorphisms in Dutch coeliac disease patients. Eur. J. Hum. Genet. 12:782.
23. Clot, F., Fulchignoni-Lataud, M. C., Renoux, C. et al. 1999. Linkage and association study of the CTLA-4 region in coeliac disease for Italian and Tunisian populations. Tissue Antigens 54:527.
24. Holopainen, P., Naluai, A. T., Moodie, S. et al. 2004. Members of the European genetics cluster on coeliac disease, candidate gene region 2q33 in European families with coeliac disease. Tissue Antigens 63:212.
25. Amundsen, S. S., Naluai, A. T., Ascher, H. et al. 2004. Genetic analysis of the CD28/CTLA4/ICOS (CELIAC3) region in coeliac disease. Tissue Antigens 64:593.
26. Brophy, K., Ryan, A. W., Thornton, J. M. et al. 2006. Haplotypes in the CTLA4 region are associated with coeliac disease in the Irish population. Genes Immun. 7:19.
27. Oaks, M. K. and Hallett, K. M.- 2000. A soluble form of CTLA-4 in patients with autoimmune thyroid disease. J. Immunol. 164:5015.
28. Saverino, D., Brizzolara, R., Simone, R. et al. 2007. Soluble CTLA-4 in autoimmune thyroid diseases: Relationship with clinical status and possible role in the immune response dysregulation. Clin. Immunol. 123:190.
29. Purohit, S., Podolsky, R., Collins, C. et al. 2005. Lack of correlation between the levels of soluble cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) and the CT-60 genotypes. J. Autoimmune. Dis. 31:2.
30. Sato, S., Fujimoto, M., Hasegawa, M. et al. 2004. Serum soluble CTLA-4 levels are increased in diffuse cutaneous systemic sclerosis. Rheumatology 43:1261.
31. Wong, C. K., Lit, L. C. W., Tam, L. S. et al. 2005. Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus. Rheumatology 44:989.
32. Wang, X. B., Kakoulidou, M., Giscombe, R. et al. 2002. Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: effect of an AT-rich gene sequence. J. Neuroimmunol. 130:224.
33. Wong, C. K., Lun, S. W. M., Ko, F. W. S. et al. 2005. Increased expression of plasma and cell surface co-stimulatory molecules CTLA-4, CD28 and CD86 in adult patients with allergic asthma. Clin. Exp. Immunol. 141:122.
34. Saverino, D., Riccio, A. M., Rogkakou, A. et al. 2009. Serum CTLA-4 in hymenoptera venom allergy end its modulation by specific immunotherapy. J. Allergy Clin. Immunol. 123:258.
35. Walker-Smith, J. A., Guandalini, S. and Schmitz, J. 1990. Working Group of European Society of Paediatric Gastroenterology and Nutrition. Revised criteria of diagnosis of coeliac disease. Arch. Dis. Child. 65:909.
36. Oberhuber, G., Granditsch, G. and Vogelsang, H. 1990. The histopathology of coeliac disease: Time for a standardized report scheme for pathologists. Eur. J. Gastroenterol. Hepatol. 11:1185.
37. Bourgey, M., Calcagno, G., Tinto, N. et al. 2007. HLA related genetic risk for coeliac disease. Gut 56:1054.
38. Hasbold, J., Gett, A. V., Rush, J. S. et al. 1999. Quantitative analysis of lymphocyte differentiation and proliferation in vitro using carboxyfluorescein diacetate succinimidyl ester. Immunol. Cell Biol. 77:516.
39. Sollid, L. M. 2002. Coeliac disease: Dissecting a complex inflammatory disorder. Nat. Rev. Immunol. 2:647.
40. Louka, A. S. and Sollid, L. M. 2003. HLA in coeliac disease: Unravelling the complex genetics of a complex disorder. Tissue Antigens 61:105.
41. Tolone, C., Cirillo, G., Papparella, A. et al. 2009. A common CTLA4 polymorphism confers susceptibility to autoimmune thyroid disease in celiac children. Dig. Liver Dis. 41:385.
42. Simone, R. and Saverino, D. 2009. The soluble CTLA-4 receptor and its emerging role in autoimmune diseases. Curr. Immunol. Rev. 5:54.
43. Ueda, H., Howson, J. M., Esposito, L. et al. 2003. Association of the T-cell regulatory gene CTLA-4 with susceptibility to autoimmune disease. Nature 423:506.
44. Kaartinen, T., Lappalainen, J., Haimila, K. et al. 2007. Genetic variation in ICOS regulates mRNA levels of ICOS and splicing isoforms of CTLA4. Mol. Immunol. 447:1644.
45. Chiovato, L., Latrofa, F., Braverman, L. E. et al. 2003. Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann. Intern. Med. 139:346.
46. Vaidya, B. and Pearce, S. 2004. The emerging role of the CTLA-4 gene in autoimmune endocrinopathies. Eur. J. Endocrinol. 150:619.
47. Berry, A., Tector, M. and Oaks, M. K. 2008. Lack of association between sCTLA-4 levels in human plasma and common CTLA-4 polymorphisms. J. Negat. Results Biomed. 12:7.
48. Oaks, M. K., Hallett, K. M., Penwell, R. T. et al. 2000. A native soluble form of CTLA-4. Cell. Immunol. 201:144.
49. Huurman, V. A., Unger, W. W., Koeleman, B. P. et al. 2007. Differential inhibition of autoreactive memory- and alloreactive naive T cell responses by soluble cytotoxic T lymphocyte antigen 4 (sCTLA4), CTLA4Ig and LEA29Y. Clin. Exp. Immunol. 150:487.
50. Clemente, M. G., Musu, M. P., Frau, F. et al. 2000. Immune reaction against the cytoskeleton in coeliac disease. Gut 47: 520.
51. Carroccio, A., Brusca, I., Iacono, G. et al. 2007. IgA anti-actin antibodies ELISA in coeliac disease: A multicentre study. Dig. Liver Dis. 39:818.
52. Fabbro, E., Rubert, L., Quaglia, S. et al. 2008. Uselessness of anti-actin antibody in celiac disease screening. Clin. Chim. Acta. 390:134.